melanotan aus II (MT-2) Unregulated peptide melanotan-II seen to

*Disclaimer: This product is intended solely for laboratory research purposes

Another peptide called PT-141, which is a metabolite of MT2, is already approved for therapy in women with hypoactive sexual desire disorder (HSDD) [14, 15]

*Correspondence: Lin Zhang, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Many different people find value in PT-141 supplementation

PT-141 has been approved by the FDA for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women